Gelonghui, April 16, 丨 Eagle Eye Technology-B (02251.HK) announced that on April 16, 2024, Shanghai Zhongyou (a wholly-owned subsidiary of the company) signed a partnership agreement with Wenzhou Lufeng and Minsheng Equity Fund to establish a partnership. The total capital pledged by all partners under the partnership agreement is RMB 500 million, of which Shanghai Zhongyou promised to invest RMB 250 million.
Partnerships shall make equity or other forms of investment permitted by applicable law, mainly in the fields of life sciences, healthcare services, smart medicine, and artificial intelligence.
Since the company focuses on using artificial intelligence technology to provide comprehensive solutions for early detection, diagnosis and health risk assessment of chronic fundus diseases and ophthalmic diseases, and also covers eye health management services such as myopia prevention and vision training, the company has been continuously seeking investment opportunities in life science, healthcare and artificial intelligence. Investing in partnerships is in line with the Group's business and development strategy, helps the company discover potential partners or acquisition targets, and brings a reserve of high-quality project opportunities. By investing in partnerships, the company will be able to broaden its investment channels and obtain a return on investment.